Print Page | Sign In
2020 Spring Meeting Disclosures

A=Author | AB=Advisory Board | C=Consultant | CO=Co-Owner | CTO=Chief Technology Officer | E=Employee | G=Grant Support 
I=Investigator | MI=Master Injector | O=Owner | OLU=Off-Label Use | R=Research | ROY=Royalties | S=Speaker | SH=Stockholder

 

Speakers

Shino Bay Aguilera, DO, FAOCD   
Allergan - S BTL - S Dermira - S 
Galderma - S L’Oreal - S Merz - S 
   
Jean-Paul Azzi, MD   
None   
   
Leslie Baumann, MD   
Burt’s Bees - AB Skin Type Solutions Franchise Systems, LLC - O, SH   
   
Edwin Bayo, JD   
None   
   
Neal Bhatia, MD   
Aclaris - AB, C, I  Dermira - AB, C, I ISDIN - AB, C, I  
Almirall - AB, C, I Encore - AB, C, I LaRoche Posay - AB, C, I 
Biofrontera - AB, C, I EPI Health - AB, C, I Leo Pharma - AB, C, I 
BiopharmX - AB, C, I Fermdale - AB, C, I  
   
Ronald Burns, DO, FACOFP   
None   
   
Steven Feldman, MD   
Abbvie - C, G, S Janssen - C, G, S Regeneron - C, G, S 
Alvotech - C Kikaku - C Sanofi - C, G, S 
Advance Medical - C Leo Pharma Inc. - C, S Sienna - C 
Caremark - C Lilly - C, G, S Sun Pharma - C, S 
Causa Technologies - CTO, SH Medical Quality Enhancement Corporation - CTO, SH Suncare Research - C 
Celgene - C, G, S Merck & Co., Inc. - C Taro - G, S 
Galderma - C, G Mylan - C UpToDate - ROY 
Gerson Lehrman Group - C Novartis - C, G, S Xenoport - C 
Guidepoint Golbal - C Ortho Dermatology - C, S Xlibris - ROY 
Informa - ROY Pfizer Inc. - C, G, S  
   
Cal Fussman   
None   
   
Steven Grekin, DO, FAOCD   
Abbvie - R Coherus – R Mimetica – R 
ADCS Holdings – E, SH Galderma – R Ortho Dermatology – R 
Allergan – R Harvest Partners Advanced Dermatology and Cosmetic Surgery – Investor Pfizer – R 
Almiral – S HealthMins – CO Promis – R 
Brickel Pharm – R HedgePath – R Valeant – R 
Celgene – S J&J Psolar – R  
   
Jeffrey Johnson, PA-C, DSDPA   
None   
   
Mark Kaufmann, MD   

BioPharmX - C

ESDIN - C Ortho Dermatologics - C 

Castle Biosciences, Inc. - C 

Klara/Goderma, Inc. - C Promius Pharma, LLC - C 

Cutanea Life Sciences - C

La Roche-Posay Laboratorie Pharmaceutique - C SciBASE - C 

Dermira - C

L’Oreal USA, Inc. - C Sensus Healthcare - AB 
Galderma - C Modernizing Medicine - C Sun Pharmaceuticals Industries Ltd. - C 
IntraDerm Pharmaceuticals - C MoleSafe, Inc. - SH UCB - C 
   
Kevin Klauer, DO, EJD, FACEP   
None   
   
Mark Lebwohl, MD  
Abbvie - R Celgene - R Meiji Seika Pharma - C 
Allergan - C Clinuvel - R Menlo - C 
Almirall - C Dermavant Sciences - C Mitsubishi - C 
Amgen - R Eli Lilly - R Neuroderm - C 
Arcutis - C, R EMD Serono - C Novartis - R 
AstraZeneca - R Evelo Biosciences - C Ortho Dermatologics - R 
Avotres Therapeutics - C Foundation for Research and Education in Dermatology - C Pfizer - C, R 
BirchBioMed Inc. - C Incyte - R Promius/Dr. Reddy’s Laboratories - C 
BMD Skincare, Inc. - C Inozyme Pharma - C Sciderm - R 
Boehringer Ingelheim - C, RJanssen Research & Development, LLC - R Theravance - C 
Bristol-Myers Squibb - C Kadmon Corp., LLC - R UCB, Inc. - R 
Cara Therapeutics - C Leo Pharmaceutucals - C, R Verrica - C 
Castle Biosciences - C Medimmune - R ViDac - R 
   
Clifford J. Lober, MD, JD   
None   
   
Arnold Mackles, MD   
The Sullivan Group - A   
   
Michael Morgan, MD   
None   
   
Michael Nowak, MD   
Modernizing Medicine - SH   
   
Leslie Rojas-Whitworth, JD   
Rojas Law, PLLC - O AOCD Board of Trustees - Trustee (Spouse)  
   
Paolo Romanelli, MD   
None   
   
Shoni Rozenberg, DO   
None   
   
Suzanne Sirota Rozenberg, DO, FAOCD   
Aerolase - S Galderma - MI  
   
Lisa Swanson, MD   
Almirall - S Janssen Biotech - AB Sanofi Regeneron - S 
Amgen - S Pfizer - S  
   
Karysse Trandem, DO   
None   
   
Michael Wein, MD   
IVG for dermatomyositis - OLU Omaliumab for cold-induced urticarial - OLU JAK inhibitors for psoriasis - OLU 
   
Jason Winn, JD   
None   
   
Edward Yob, DO, FAOCD   
None   
   
   
AOCD Board of Trustees Disclosures 
John Minni, DO, FAOCD - President   
Board Certified in Dermatology by American Osteopathic Board of Dermatology  
Abbvie - SJanssen - S Novartis - S 
Galderma - SLeo - S Promius - S 
   
Reagan Anderson, DO, FAOCD - President-Elect  
Board Certified in Dermatology by American Osteopathic Board of Dermatology  
Abbvie - I Doctor’s Quarterly - O Novartis - I 
The Business of Medicine - O HealthMins - CO Your Health University - O 
   
David Cleaver, DO, FAOCD - First Vice-President  

Board Certified in Dermatology by American Osteopathic Board of Dermatology

 
Abbvie - S  
   
Amy Spizuoco, DO, FAOCD - Second Vice-President   
Board Certified in Dermatology by American Osteopathic Board of Dermatology  
Pfizer - S   
   
Steven Grekin, DO, FAOCD - Secretary-Treasurer 
  
Board Certified in Dermatology by American Osteopathic Board of Dermatology  
Abbvie - R Coherus – R Mimetica – R 
ADCS Holdings – E, SH Galderma – R Ortho Dermatology – R 
Allergan – R Harvest Partners Advanced Dermatology and Cosmetic Surgery – Investor Pfizer – R 
Almiral – S HealthMins – CO Promis – R 
Brickel Pharm – R HedgePath – R Valeant – R 
Celgene – S J&J Psolar – R  
   
Danica Alexander, DO, FAOCD - Trustee   
Board Certified in Dermatology by American Osteopathic Board of Dermatology  
None   
   
Steven Brooks, DO, FAOCD - Trustee   
Board Certified in Dermatology by American Osteopathic Board of Dermatology  
Pfizer - S   
   
Jonathan Crane, DO, FAOCD - Trustee   
Board Certified in Dermatology by American Osteopathic Board of Dermatology  
3M - C, R, S Fujisawa - C, R, S Novartis - C, R, S 
Allergan - C, R, S Genetech Inc. - C, R, S  
Candella Laser Company - C, R, S Glaxo Smith Klein - C, R, S  
   
Ralph Fiore, II, DO, FAOCD - Trustee  
Board Certified in Dermatology by American Osteopathic Board of Dermatology  
None   
   
Carlos Gomez-Meade, DO, FAOCD - Trustee   
Board Certified in Dermatology by American Osteopathic Board of Dermatology  
None   
   
Jerome Obed, DO, FAOCD - Trustee   
Board Certified in Dermatology by American Osteopathic Board of Dermatology  
None   
   
Lacey Walls, DO, FAOCD - Trustee   
Board Certified in Dermatology by American Osteopathic Board of Dermatology  
None   
   
Michael Whitworth, DO, FAOCD - Trustee   
Board Certified in Dermatology by American Osteopathic Board of Dermatology  
None   
   
Daniel Ladd, DO, FAOCD - Immediate Past President  
Board Certified in Dermatology by American Osteopathic Board of Dermatology  
Sensus Healthcare - Physician Training Shade Project - Director, Officer or Employee (Spouse) SkinCure Oncology: Medical Officer, Minority Shareholder 
Shade Project - Director, Officer or Employee   
   
   
AOCD CME Committee Disclosures 
Nathan Cleaver, DO, FAOCD   
Board Certified in Dermatology by American Osteopathic Board of Dermatology  
Castle Biosciences - S   
   
Laura DeStefano, DO, FAOCD   
Board Certified in Dermatology by American Osteopathic Board of Dermatology  
None   
   
Dwayne Montie, DO, FAOCD   
Board Certified in Dermatology by American Osteopathic Board of Dermatology  
None   
   
Stephen Verral, DO, FAOCD   
Board Certified in Dermatology by American Osteopathic Board of Dermatology  
None   
   
   
AOCD Staff Disclosures 
Marsha Wise - Executive Director 
  
None   
   
John Grogan - Member Services and Digital Media Coordinator  
None   
   
John Wise - Director of Events and Information Technology  
None   
   
Shelley Wood - Education and Corporate Support Coordinator  
None   
   

2902 North Baltimore Street | P.O. Box 7525 | Kirksville, Missouri 63501

660-665-2184 | 1-800-449-2623 | 660-627-2623

General Terms of Use Policy
The AOCD web site and AOCD apps contain copyrighted material and other proprietary information, which may include, but is not limited to: text, software, photos, video, graphics and audio. It is not permitted to modify, publish, transmit, participate in the transfer or sale, create derivative works, or in any way exploit any of the content, in whole or in part.

The AOCD limits permission for downloading education material for personal use only.